The use of catheter-directed thrombolysis to treat arterial occlusions

Lancashire Teaching Hospitals NHS Foundation Trust did not have the information requested.

Dear Lancashire Teaching Hospitals NHS Foundation Trust,

I am writing to you under the Freedom of Information Act 2000 to request the following information:

With regards to the use of catheter-directed thombolysis to treat acute arterial occlusions occurring any where between the proximal end of the Common Iliac Artery to the distal end of the Common Femoral Artery, that have received no prior treatment i.e its the first recorded / diagnosed arterial occlusion of an untouched native vessel.

Please could you answer the following:

1. The number of catheter-directed thombolysis treatments that have been performed during the last 3 years?.

2. The number of successful treatments during the past 3 years, success defined as the vessel still being patent at follow up preferably over 90 days but dependant on how you log/monitor this etc?.

3. What clinical guidance document(s) if any are in use for determining/aiding the decision for the use of catheter-directed thrombolysis as a viable treatment if administered within a certain time frame?

4.What approximate time frame would the Lancashire Teaching Hospitals NHS Foundation Trust, consider to be an acceptable time frame for the use of catheter-directed thrombolysis in the aforementioned vessels?
To clarify what l am interested in, an example response would be: "Catheter-directed thrombolysis may be a viable treatment if administered within 4 - 120 hours of the occlusive event etc

I thank you for your time and look forward to your response.

Yours faithfully,

Mr. Kent

Freedom of Information (LTHTR), Lancashire Teaching Hospitals NHS Foundation Trust

Dear Mr Kent,

Thank you for your request for information submitted under the Freedom of
Information Act.

We can confirm that Lancashire Teaching Hospitals NHS Foundation Trust
will reply on or before 29/4/19.

Regards,

Freedom of Information Officer
Lancashire Teaching Hospitals NHS Foundation Trust
c/o The Medical Director’s Office
Royal Preston Hospital
Sharoe Green Lane
Fulwood, Preston, PR2 9HT
Email : [email address]
www.lancsteachinghospitals.nhs.uk
@LancsHospitals
Excellent care with compassion

show quoted sections

Hodson Sam (LTHTR), Lancashire Teaching Hospitals NHS Foundation Trust

4 Attachments

Dear Mr Kent,

Thank you for your request for information submitted under the Freedom of
Information Act. I can confirm that the trust does not hold the
information requested, please see our response below and details of the
review procedure attached.

 

 

FOI Request 6424

 

With regards to the use of catheter-directed thrombolysis to treat acute
arterial occlusions occurring anywhere between the proximal end of the
Common Iliac Artery to the distal end of the Common Femoral Artery, that
have received no prior treatment i.e. it’s the first recorded / diagnosed
arterial occlusion of an untouched native vessel.

 

Please could you answer the following?

 

1. The number of catheter-directed thrombolysis treatments that have been
performed during the last 3 years?

 

2. The number of successful treatments during the past 3 years, success
defined as the vessel still being patent at follow up preferably over 90
days but dependant on how you log/monitor this etc.?

 

 

3. What clinical guidance document(s) if any are in use for
determining/aiding the decision for the use of catheter-directed
thrombolysis as a viable treatment if administered within a certain time
frame?

 

 

4.What approximate time frame would the Lancashire Teaching Hospitals NHS
Foundation Trust, consider to be an acceptable time frame for the use of
catheter-directed thrombolysis in the aforementioned vessels?

 

To clarify what l am interested in, an example response would be:
"Catheter-directed thrombolysis may be a viable treatment if administered
within 4 - 120 hours of the occlusive event etc.

 

Trust response: Information not held, the trust does not utilise
catheter-directed thrombolysis to treat acute arterial occlusions (the
trust uses intravenous thrombolysis only).

 

Regards,

 

 

Freedom of Information Officer

Lancashire Teaching Hospitals NHS Foundation Trust
c/o The Medical Director’s Office

Royal Preston Hospital

Sharoe Green Lane

Fulwood, Preston, PR2 9HT
Email : [1][email address]

[2]www.lancsteachinghospitals.nhs.uk
[3]cid:image001.png@01D4D59E.43E22470@[4]LancsHospitals
Excellent care with compassion

  [5]cid:image001.jpg@01D34811.2262F1B0     [6]cid:image001.jpg@01D47FE4.94089B10

Ranked #1 NHS Clinical Digital Maturity Index Acute rankings June 2018

  

show quoted sections

Dear Hodson Sam (LTHTR),

Thank you for processing my request.

Yours sincerely,
Mr. Kent